• RHEB Neddylation Drives mTORC1 in Liver Cancer

  2026-09-30

  The reference study identifies RHEB as a non-cullin substrate of the UBE2F–SAG neddylation machinery and maps a functional modification to lysine 169. By combining cellular, biochemical, liver-specific genetic, and clinical association analyses, it links RHEB neddylation to mTORC1 activation, steatosis, liver tumorigenesis, and hepatocellular carcinoma outcomes.

• c-Myc Tag Peptide: Assay Control to Translation

  2026-09-30

  A translational perspective on how the c-Myc tag Peptide improves epitope-specific assay control, clarifies protein-regulation mechanisms, and supports more rigorous interpretation of cancer and innate-immunity studies.

• ALC-0159 PEG Lipid for mRNA LNP Workflows

  2026-09-29

  Use ALC-0159 as a controlled PEG-lipid variable when optimizing mRNA lipid nanoparticles for expression, stability, and immune-readout studies. This workflow connects formulation development with cancer-immunotherapy assays while clearly separating product-specific evidence from findings reported for complete vaccine systems.

• JNJ-26481585: Workflow for Resistance Research

  2026-09-29

  JNJ-26481585 (Quisinostat) combines potent HDAC inhibition with a practical workflow for studying TRIM21–ERK1/2 signaling, apoptosis, and treatment resistance. This guide translates the pituitary adenoma findings into reproducible cell-based assays, mechanism controls, and tumor-model validation strategies.

• TRIM66 and Monogenic Olfactory Receptor Choice

  2026-09-28

  The reference study identifies TRIM66 as an epigenetic repressor that helps convert initially polygenic olfactory receptor expression into the mature one-neuron–one-receptor state. Genetic, molecular, and behavioral evidence links TRIM66-dependent enhancer repression to olfactory sensory neuron identity, neural activity, and innate olfactory behavior.

• Temafloxacin Activity Against Gram-Positive Bacteria

  2026-09-28

  This 1991 study paired broth microdilution testing of bloodstream isolates with a review of published evidence to assess temafloxacin against clinically important Gram-positive cocci. It reported greater in-vitro activity than ciprofloxacin or ofloxacin against the tested staphylococci and pneumococci, while showing that assay conditions such as urine composition and magnesium concentration can influence interpretation.

• Rifampin as a Causal Probe of Bacterial Transcription

  2026-09-27

  Rifampin is more than a transcription inhibitor: it can help researchers separate changes in RNA synthesis from downstream effects on RNA stability, translation, and growth. This article explains how to interpret that perturbation, design controls, and recognize where its conclusions do—and do not—extend.

• ICI 118,551 Hydrochloride: Designing β2-AR Assays

  2026-09-26

  ICI 118,551 hydrochloride is a pharmacological tool for probing β2-adrenergic receptor signaling. This guide focuses on experimental design, controls, and interpretation—and explains why a stroke-inflammation study offers a useful lesson in causal evidence, not direct validation of this compound.

• How O-GlcNAcylation Drives Wnt-Dependent Bone Formation

  2026-09-25

  The study identifies O-GlcNAcylation as a metabolic link between Wnt stimulation and osteoblast activity: Wnt3a stabilizes PDK1 through modification at Ser174, promoting aerobic glycolysis and bone formation. Its genetic, cellular, and in vivo findings suggest that this nutrient-sensitive protein modification is necessary for effective Wnt-driven osteogenesis and fracture repair.

• SETD7 Loss Promotes White-Fat Browning in Obese Mice

  2026-09-25

  The study identifies SETD7 as a brake on thermogenic activity in inguinal white adipose tissue: reducing Setd7 enhanced browning and thermogenic responses, while protecting mice from high-fat-diet-associated weight gain and metabolic impairment. Its proposed Adcy7–Sirt1–CREB1 pathway offers a mechanistic link between SETD7 depletion and beige-adipocyte activity, while leaving important questions about therapeutic translation and human relevance unresolved.

• 3X (DYKDDDDK) Peptide for Protein Turnover Studies

  2026-09-24

  See how the 3X (DYKDDDDK) Peptide can support experiments that distinguish protein detection from mechanistic evidence. A Chlamydia effector study offers a practical framework for interpreting tagged-protein abundance, degradation, and function.

• Selective Autophagy Sets IRF3 Stability and IFN Balance

  2026-09-24

  Wu and colleagues describe a virus-load-dependent mechanism in which CALCOCO2/NDP52-mediated selective autophagy degrades IRF3, while PSMD14 protects IRF3 by removing K27-linked ubiquitin chains at lysine 313. The work connects IRF3 turnover to type I interferon output and immune restraint, emphasizing that antiviral signaling depends on controlling transcription-factor abundance as well as activation.

• In Vitro Drug Response: Growth Arrest vs Cell Death

  2026-09-23

  Hannah R. Schwartz’s 2022 dissertation highlights a key interpretive problem in cancer pharmacology: relative viability and fractional viability capture different parts of a drug response. Its central finding—that most drugs affect both proliferation and cell death, but to different degrees and on different timelines—supports measuring and interpreting these outcomes separately.

• Quercetin as a PI3K Inhibitor in Research

  2026-09-23

  Quercetin is a dietary flavonoid and research-use PI3K inhibitor with reported effects on inflammatory signaling, mitochondria, apoptosis, and cell cycle regulation. Preclinical LPS-induced depression data connect quercetin with reduced NLRP3-associated neuroinflammation, but the findings do not establish clinical efficacy.

• One-step TUNEL FITC Apoptosis Detection Kit

  2026-09-22

  The One-step TUNEL FITC Apoptosis Detection Kit uses FITC-labeled dUTP incorporation to visualize DNA fragmentation associated with apoptosis in tissue sections and cultured cells. Its fluorescence readout supports microscopy and flow cytometry, while appropriate controls are required because TUNEL detects DNA strand breaks rather than proving a single death pathway.

8083 records 1/539 page Next 12345 下5页 Last page